Company intelligence / Profile preview

Syntegre

Ownership: Private
Development stage: Commercial

Overview

Syntegre is a company focused on developing advanced digital solutions for dentistry. Their offerings include digital workflows, 3D printing integration, and software/hardware systems designed to improve efficiency in dental practices and laboratories. There is no evidence that Syntegre develops therapeutics or engages in clinical trials typical of biotech/pharma companies[2].

Therapeutic areas: Other
Modalities: Device
Industry: Digital Health Medical Devices

Drug pipeline

5 assets

EVOCURE MODEL

Commercial

Indications: Dental models

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Syntegre.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Syntegre.

Explore the full profile